242 related articles for article (PubMed ID: 32106239)
21. Comparison of Whole-Body DWI and
Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
[No Abstract] [Full Text] [Related]
22. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C; Crimì F; Guolo A; Varin C; De March E; Vio S; Ponzoni A; Barilà G; Lico A; Branca A; De Biasi E; Gherlinzoni F; Scapin V; Bissoli E; Berno T; Zambello R
Clin Radiol; 2017 Oct; 72(10):850-857. PubMed ID: 28587715
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of Schmorl Nodes From Bone Metastases of the Spine: Use of Apparent Diffusion Coefficient Derived From DWI and Fat Fraction Derived From a Dixon Sequence.
Lee JH; Park S
AJR Am J Roentgenol; 2019 Nov; 213(5):W228-W235. PubMed ID: 31461318
[No Abstract] [Full Text] [Related]
24. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
Park GE; Jee WH; Lee SY; Sung JK; Jung JY; Grimm R; Son Y; Paek MY; Min CK; Ha KY
PLoS One; 2018; 13(12):e0208860. PubMed ID: 30557373
[TBL] [Abstract][Full Text] [Related]
25. Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma.
Wang J; Zhang B; Zhang R; Zhang L; Jiang W; Jiang Y
Medicine (Baltimore); 2021 Sep; 100(35):e27131. PubMed ID: 34477159
[TBL] [Abstract][Full Text] [Related]
26. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
[TBL] [Abstract][Full Text] [Related]
27. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
28. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
[TBL] [Abstract][Full Text] [Related]
29. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
[No Abstract] [Full Text] [Related]
30. Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images.
Danner A; Brumpt E; Alilet M; Tio G; Omoumi P; Aubry S
Diagn Interv Imaging; 2019 Sep; 100(9):513-519. PubMed ID: 31130374
[TBL] [Abstract][Full Text] [Related]
31. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR.
Hansen CT; Pedersen PT; Nielsen LC; Abildgaard N
Eur J Haematol; 2014 Nov; 93(5):407-13. PubMed ID: 24809596
[TBL] [Abstract][Full Text] [Related]
33. [Value of mDIXON-Quant sequence, diffusion-weighted imaging in quantitatively diagnosing the sacroiliitis stages].
An YY; Li HX; Zhan Y; Lei XW
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(37):2908-2912. PubMed ID: 29050160
[No Abstract] [Full Text] [Related]
34. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
[TBL] [Abstract][Full Text] [Related]
35. Apparent Diffusion Coefficient of Normal Abdominal Organs and Bone Marrow From Whole-Body DWI at 1.5 T: The Effect of Sex and Age.
Lavdas I; Rockall AG; Castelli F; Sandhu RS; Papadaki A; Honeyfield L; Waldman AD; Aboagye EO
AJR Am J Roentgenol; 2015 Aug; 205(2):242-50. PubMed ID: 26204271
[TBL] [Abstract][Full Text] [Related]
36. [Application of MRI Water-Fat Separation Technology in Patients with Multiple Myeloma].
Gu YW; Wu Y; Yan RX; Jiang XN; Ju XY; Shi X; Feng XQ; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):183-188. PubMed ID: 35123624
[TBL] [Abstract][Full Text] [Related]
37. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC; Verstraete KL
Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
[TBL] [Abstract][Full Text] [Related]
38. Does chemical shift imaging offer a biomarker for the diagnosis and assessment of disease severity in multiple myeloma?: A cross-sectional study.
Takasu M; Tanitame K; Baba Y; Akiyama Y; Tamura T; Kondo S; Maeda S; Sakai A; Awai K
Medicine (Baltimore); 2021 Feb; 100(6):e24358. PubMed ID: 33578532
[TBL] [Abstract][Full Text] [Related]
39. Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Li Y; Zhang S
Quant Imaging Med Surg; 2021 Aug; 11(8):3767-3780. PubMed ID: 34341748
[TBL] [Abstract][Full Text] [Related]
40. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
